Currently, emerging studies demonstrate gastrointestinal infection is one of the clinical presentations of COVID-19, because the convincing evidence showing the high expression of ACE2 in intestinal enterocytes and positive viral RNA in the rectal swabs (Jiang et al., 2020; Lamers et al., 2020). Here, ACE2 is linked to digestive system infectious disorder.